CVS, FTC and Cigna
The Cigna Group (CI) is a global health services company worth a market cap of $79.2 billion. The Bloomfield, ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
In a report released yesterday, Lance Wilkes from Bernstein maintained a Buy rating on Cigna (CI – Research Report), with a price target of ...
CVS Caremark Rx blasted the findings for cherry picking certain drugs in an effort to push what it called an 'anti-PBM' ...
A Virginia mother-of-three who lost most of her left arm in a June 2024 shark attack recently learned her health insurer, ...
Cigna and Centene were among a dozen companies that appeared on the initial JPM agenda that have bowed out of the conference.
Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly more than the national average ...
FTC report reveals significant markups by top PBMs on specialty drugs, driving $7.3 billion in revenue and raising costs for ...
Cigna Healthcare, the health benefits division of The Cigna Group (NYSE: CI), today announced a new offering in collaboration with Progyny, Inc (Nasdaq: PGNY) that makes best-in-class fertility ...
A new offering in collaboration with Progyny, Inc makes fertility/family-building services more accessible and equitable.
As you can see from the chart above the percentage of shares that are sold short for Cigna has grown since its last report.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback